Patient preferences for treatment in type 2 diabetes: the Italian discrete-choice experiment analysis.

Giulio MarchesiniPatrizio PasqualettiRoberto AnichiniSalvatore CaputoGiuseppe MemoliPaola PonzaniVeronica ResiManfredi RizzoGaetano ServiddioGiorgio Zanette

Published in: Acta diabetologica (2018)

Easy-to-deliver, injectable treatment is preferred in T2DM, independently of treatment history, and previous experience with GLP-1RAs strengthens patients' willingness to accept injectable drugs.

Keyphrases

type diabetes
cardiovascular disease
newly diagnosed
metabolic syndrome
skeletal muscle
chronic kidney disease
adipose tissue
weight loss
hyaluronic acid